Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Shuchita Kaila, PhD
Articles
Impact of Initial Days' Supply of Angiotensin II Receptor Blockers
Becky A. Briesacher, PhD;Shuchita Kaila, PhD;Hassan Fouayzi, MS;Chunlin Qian, PhD;Philip P. Gerbino, PharmD
February 17th 2016For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
Read More
Latest Updated Articles
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
